Media Summary: The healthcare sector (XLV) has been outperforming to kick off 2025, though this has not been the case over the past several ... GLP-1 weight-loss drugs have pushed the biotech sector to Futurum president Dan O'Brian sits down with Sam Vadas to talk about Nvidia's (NVDA) earnings and the ripple effects

What S Behind Yahoo Finance S Latest Update On Axovant Gene Therapies - Detailed Analysis & Overview

The healthcare sector (XLV) has been outperforming to kick off 2025, though this has not been the case over the past several ... GLP-1 weight-loss drugs have pushed the biotech sector to Futurum president Dan O'Brian sits down with Sam Vadas to talk about Nvidia's (NVDA) earnings and the ripple effects Earlier this week, the Trump administration froze and then rescinded the freeze on federal funding for several programs, including ... You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. AI is moving from chatbots to ... You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. The AI boom is reshaping ...

Photo Gallery

Sickle cell gene editing faces market hurdles: Analyst
Bluebird stock pops after FDA approves its gene therapy drug
BioMarin CEO: There are biotech companies 'that probably should not be on the market today’
This factor will set apart competing gen AI tools: Analyst
AstraZeneca beats Q2 earnings estimates, sees strong sales of cancer treatment drugs
2025 will be 'fairly challenging' for Moderna: Analyst
Does Healthcare's outperformance signal a turnaround?
Investing in biotech outside of weight-loss drugs
Vaccines: There's 'so much noise' around facts, Moderna CEO explains
How pet medicine stocks could cushion your healthcare investments from Trump changes
NVDA Earnings & Ripple Effects Across the AI, Quantum Industries
Biotech walks a 'tightrope' amid unclear regulations
Sponsored
Sponsored
View Detailed Profile
Sickle cell gene editing faces market hurdles: Analyst

Sickle cell gene editing faces market hurdles: Analyst

"The FDA approved a

Bluebird stock pops after FDA approves its gene therapy drug

Bluebird stock pops after FDA approves its gene therapy drug

Bluebird #Bluebirdstock #Bluebirdearnings #YahooFinannce

Sponsored
BioMarin CEO: There are biotech companies 'that probably should not be on the market today’

BioMarin CEO: There are biotech companies 'that probably should not be on the market today’

Biotech BioMarin CEO JJ Bienaimé joins

This factor will set apart competing gen AI tools: Analyst

This factor will set apart competing gen AI tools: Analyst

Nvidia's (NVDA)

AstraZeneca beats Q2 earnings estimates, sees strong sales of cancer treatment drugs

AstraZeneca beats Q2 earnings estimates, sees strong sales of cancer treatment drugs

AstraZeneca #youtube #

Sponsored
2025 will be 'fairly challenging' for Moderna: Analyst

2025 will be 'fairly challenging' for Moderna: Analyst

Moderna (MRNA) shares

Does Healthcare's outperformance signal a turnaround?

Does Healthcare's outperformance signal a turnaround?

The healthcare sector (XLV) has been outperforming to kick off 2025, though this has not been the case over the past several ...

Investing in biotech outside of weight-loss drugs

Investing in biotech outside of weight-loss drugs

GLP-1 weight-loss drugs have pushed the biotech sector to

Vaccines: There's 'so much noise' around facts, Moderna CEO explains

Vaccines: There's 'so much noise' around facts, Moderna CEO explains

It

How pet medicine stocks could cushion your healthcare investments from Trump changes

How pet medicine stocks could cushion your healthcare investments from Trump changes

Moderna shares

NVDA Earnings & Ripple Effects Across the AI, Quantum Industries

NVDA Earnings & Ripple Effects Across the AI, Quantum Industries

Futurum president Dan O'Brian sits down with Sam Vadas to talk about Nvidia's (NVDA) earnings and the ripple effects

Biotech walks a 'tightrope' amid unclear regulations

Biotech walks a 'tightrope' amid unclear regulations

Earlier this week, the Trump administration froze and then rescinded the freeze on federal funding for several programs, including ...

Why investors should care about the rise of quantum AI

Why investors should care about the rise of quantum AI

You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. AI is moving from chatbots to ...

Nvidia and semiconductors still lead, but new winners emerge

Nvidia and semiconductors still lead, but new winners emerge

You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. The AI boom is reshaping ...

Surgeon General: We have the supplies to vaccinate 'all 28 million children  ages 5 to 11'

Surgeon General: We have the supplies to vaccinate 'all 28 million children ages 5 to 11'

COVID19vaccines #coronavirusvaccines #YFAMS #YahooAMS In a